Research and Markets: Therapeutic Drug Monitoring 2015 - Technologies, Markets, and Companies Analysis 2014-2024
March 05 2015 - 5:07AM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/m99wg2/therapeutic_drug)
has announced the addition of Jain PharmaBiotech's new report
"Therapeutic Drug Monitoring - Technologies, Markets, and
Companies" to their offering.
This report deals with therapeutic drug monitoring, a
multi-disciplinary clinical specialty, aimed at improving patient
care by monitoring drug levels in the blood to individually adjust
the dose of drugs for improving outcome. TDM is viewed as a
component of personalized medicine that interacts with several
other disciplines including pharmacokinetics and pharmacogenetics.
One chapter is devoted to monitoring of drugs of abuse (DoA).
Various technologies used for well-known DoA are described. A
section on drug abuse describes methods of detection of
performance-enhancing drugs. TDM market is analyzed from 2014 to
2024 according to technologies as well as geographical
distribution. Global market for DoA testing was also analyzed from
2014 to 2024 and divided according to the area of application.
Unmet needs and strategies for development of markets for TDM are
discussed. The report contains profiles of 27 companies involved in
developing tests and equipment for drug monitoring along with their
collaborations. The text is supplemented with 17 tables, 6 figures
and 180 selected references from literature.
Benefits of this report
- Up-to-date one-stop information on therapeutic drug
monitoring
- Description of 27 companies involved with their collaborations
in this area
- Market analysis 2014-2024/
- Market values in major regions
- Strategies for developing markets for therapeutic drug
monitoring
- A selected bibliography of 180 publications
- Text is supplemented by 17 tables and 6 figures
Who should read this report?
- Biotechnology companies developing assays and equipment for
drug monitoring
- Reference laboratories providing drug monitoring services
- Pharmaceutical companies interested in companion tests for
monitoring their drugs
- Clinical pharmacologists interested in integrating therapeutic
drug monitoring with pharmacogenetics for development of
personalized medicine.
Key Topics Covered:
Executive Summary
1. Introduction
2. Technologies for TDM
3. Drug Monitoring Instruments
4. Applications of TDM
5. Drugs Requiring Monitoring
6. Monitoring of Biological Therapies
7. Monitoring of Drug Abuse
8. Markets for TDM
9. Companies
10. References
For more information visit
http://www.researchandmarkets.com/research/m99wg2/therapeutic_drug
Source: Jain PharmaBiotech
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: Pharmaceuticals